Gastrointestinal perforations in patients treated with erlotinib: A report of two cases with fatal outcome and literature review

Highlights • Two cases of gastrointestinal perforation (GIP), induced by erlotinib. • Only 1 case of erlotinib-associated GIP under monotherapy reported in the literature. • Risk factors: corticosteroids, medications modifying erlotinib metabolism, diarrhea.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2016-09, Vol.99, p.76-78
Hauptverfasser: Gass-Jégu, Florence, Gschwend, Anthony, Gairard-Dory, Anne-Cécile, Mennecier, Bertrand, Tebacher-Alt, Martine, Gourieux, Bénédicte, Quoix, Élisabeth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Two cases of gastrointestinal perforation (GIP), induced by erlotinib. • Only 1 case of erlotinib-associated GIP under monotherapy reported in the literature. • Risk factors: corticosteroids, medications modifying erlotinib metabolism, diarrhea.
ISSN:0169-5002
1872-8332
DOI:10.1016/j.lungcan.2016.06.012